234080.KS
JW Lifescience Corporation [234080.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
234080.KS Stock Summary
Top 10 Correlated ETFs
234080.KS
Top 10 Correlated Stocks
234080.KS
In the News
234080.KS Financial details
Company Rating
-
Market Cap
187.98B
Income
28.14B
Revenue
206.86B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
256
Optionable
No
Shortable
Yes
Earnings
30 Jan 2024
P/E
8.83
Forward P/E
-
PEG
1
P/S
0.97
P/B
1.32
P/C
-
P/FCF
16.37
Quick Ratio
0.85
Current Ratio
1.08
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.82K
EPS next Y
-
EPS next Q
-
EPS this Y
88.11%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
5.58%
Revenue last 5Y
3.98%
Revenue Q/Q
4.88%
EPS Q/Q
125.39%
-
-
-
-
SMA20
0.62%
SMA50
8.6%
SMA100
-1.92%
Inst Own
-
Inst Trans
-
ROA
9%
ROE
16%
ROC
0.2%
Gross Margin
25%
Oper. Margin
15%
Profit Margin
11%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
11500.0-15160.0
52W High
-24.21%
52W Low
-0.09%
RSI
64.27
Rel Volume
1.08
Avg Volume
18.92K
Volume
20.37K
Perf Week
1.77%
Perf Month
0.97%
Perf Quarter
5.32%
Perf Half Y
5.61%
-
-
-
-
Beta
0.561
-
-
Volatility
100.35%, 263.02%
Prev Close
0.09%
Price
11490
Change
0.52%
Company Profile
- Volume Average 18.92K
- Market Capitalization 187.98B
- Employee 256
- CEO Sungnam Cha
- Headquarters Dangjin-si,KR
- IPO Date 2016-10-27
-
Website
https://www.jw-lifescience.co.kr 
JW Lifescience Corporation engages in the development, production, and sale of infusion solutions in South Korea and internationally. It offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin, South Korea.
